Logo image of SYENS.BR

SYENSQO SA (SYENS.BR) Stock Fundamental Analysis

EBR:SYENS - Euronext Brussels - BE0974464977 - Common Stock - Currency: EUR

77.76  +1.02 (+1.33%)

Fundamental Rating

4

Overall SYENS gets a fundamental rating of 4 out of 10. We evaluated SYENS against 69 industry peers in the Chemicals industry. SYENS has only an average score on both its financial health and profitability. SYENS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

SYENS had positive earnings in the past year.
In the past year SYENS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: SYENS reported negative net income in multiple years.
In the past 5 years SYENS always reported a positive cash flow from operatings.
SYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFSYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

The Return On Assets of SYENS (-0.71%) is comparable to the rest of the industry.
SYENS has a Return On Equity of -1.30%. This is comparable to the rest of the industry: SYENS outperforms 40.58% of its industry peers.
SYENS has a Return On Invested Capital (4.38%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SYENS is in line with the industry average of 6.84%.
The last Return On Invested Capital (4.38%) for SYENS is well below the 3 year average (8.47%), which needs to be investigated, but indicates that SYENS had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.71%
ROE -1.3%
ROIC 4.38%
ROA(3y)2.81%
ROA(5y)0.13%
ROE(3y)7.26%
ROE(5y)-1.97%
ROIC(3y)8.47%
ROIC(5y)7.63%
SYENS.BR Yearly ROA, ROE, ROICSYENS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

With a decent Operating Margin value of 9.25%, SYENS is doing good in the industry, outperforming 68.12% of the companies in the same industry.
In the last couple of years the Operating Margin of SYENS has declined.
SYENS has a Gross Margin (31.11%) which is comparable to the rest of the industry.
SYENS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.25%
PM (TTM) N/A
GM 31.11%
OM growth 3Y-4.48%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5YN/A
SYENS.BR Yearly Profit, Operating, Gross MarginsSYENS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

More info and screens

5

2. Health

2.1 Basic Checks

SYENS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
SYENS has less shares outstanding than it did 1 year ago.
The debt/assets ratio for SYENS has been reduced compared to a year ago.
SYENS.BR Yearly Shares OutstandingSYENS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SYENS.BR Yearly Total Debt VS Total AssetsSYENS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 2.32 indicates that SYENS is not a great score, but indicates only limited risk for bankruptcy at the moment.
SYENS has a Altman-Z score (2.32) which is in line with its industry peers.
SYENS has a debt to FCF ratio of 25.36. This is a negative value and a sign of low solvency as SYENS would need 25.36 years to pay back of all of its debts.
With a Debt to FCF ratio value of 25.36, SYENS perfoms like the industry average, outperforming 53.62% of the companies in the same industry.
A Debt/Equity ratio of 0.43 indicates that SYENS is not too dependend on debt financing.
SYENS's Debt to Equity ratio of 0.43 is in line compared to the rest of the industry. SYENS outperforms 55.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 25.36
Altman-Z 2.32
ROIC/WACC0.64
WACC6.87%
SYENS.BR Yearly LT Debt VS Equity VS FCFSYENS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.27 indicates that SYENS has no problem at all paying its short term obligations.
SYENS has a Current ratio of 2.27. This is in the better half of the industry: SYENS outperforms 73.91% of its industry peers.
A Quick Ratio of 1.56 indicates that SYENS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.56, SYENS is in the better half of the industry, outperforming 76.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.56
SYENS.BR Yearly Current Assets VS Current LiabilitesSYENS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

2

3. Growth

3.1 Past

The earnings per share for SYENS have decreased strongly by -102.63% in the last year.
Looking at the last year, SYENS shows a decrease in Revenue. The Revenue has decreased by -3.10% in the last year.
SYENS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.31% yearly.
EPS 1Y (TTM)-102.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67.55%
Revenue 1Y (TTM)-3.1%
Revenue growth 3Y4.31%
Revenue growth 5YN/A
Sales Q2Q%-7.14%

3.2 Future

SYENS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.94% yearly.
Based on estimates for the next years, SYENS will show a small growth in Revenue. The Revenue will grow by 3.51% on average per year.
EPS Next Y6.78%
EPS Next 2Y12%
EPS Next 3Y12.22%
EPS Next 5Y7.94%
Revenue Next Year-1.27%
Revenue Next 2Y1.41%
Revenue Next 3Y2.41%
Revenue Next 5Y3.51%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SYENS.BR Yearly Revenue VS EstimatesSYENS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
SYENS.BR Yearly EPS VS EstimatesSYENS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.85 indicates a rather expensive valuation of SYENS.
Based on the Price/Earnings ratio, SYENS is valued a bit cheaper than 62.32% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.87. SYENS is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 11.76, which indicates a very decent valuation of SYENS.
Based on the Price/Forward Earnings ratio, SYENS is valued a bit cheaper than 75.36% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SYENS to the average of the S&P500 Index (35.34), we can say SYENS is valued rather cheaply.
Industry RankSector Rank
PE 20.85
Fwd PE 11.76
SYENS.BR Price Earnings VS Forward Price EarningsSYENS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

SYENS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SYENS is cheaper than 73.91% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as SYENS.
Industry RankSector Rank
P/FCF 66.78
EV/EBITDA 7.23
SYENS.BR Per share dataSYENS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SYENS does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as SYENS's earnings are expected to grow with 12.22% in the coming years.
PEG (NY)3.08
PEG (5Y)N/A
EPS Next 2Y12%
EPS Next 3Y12.22%

More info and screens

1

5. Dividend

5.1 Amount

SYENS has a Yearly Dividend Yield of 1.48%.
Compared to an average industry Dividend Yield of 3.03, SYENS has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.36, SYENS is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.48%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
SYENS.BR Yearly Dividends per shareSYENS.BR Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5

5.3 Sustainability

SYENS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-210.34%
EPS Next 2Y12%
EPS Next 3Y12.22%
SYENS.BR Yearly Income VS Free CF VS DividendSYENS.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 500M -500M -1B

More info and screens

SYENSQO SA

EBR:SYENS (8/15/2025, 7:00:00 PM)

77.76

+1.02 (+1.33%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-31 2025-07-31/dmh
Earnings (Next)11-06 2025-11-06
Inst Owners23.15%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.08B
Analysts80.74
Price Target82.07 (5.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.48%
Yearly Dividend1.63
Dividend Growth(5Y)N/A
DP-210.34%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-31.92%
Min EPS beat(2)-59.05%
Max EPS beat(2)-4.8%
EPS beat(4)0
Avg EPS beat(4)-27.51%
Min EPS beat(4)-59.05%
Max EPS beat(4)-4.8%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.4%
Min Revenue beat(2)-4.63%
Max Revenue beat(2)-2.18%
Revenue beat(4)0
Avg Revenue beat(4)-3.18%
Min Revenue beat(4)-4.63%
Max Revenue beat(4)-1.3%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.54%
PT rev (3m)-4.69%
EPS NQ rev (1m)-1.07%
EPS NQ rev (3m)-22.84%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.72%
Revenue NQ rev (3m)-6.77%
Revenue NY rev (1m)-2.46%
Revenue NY rev (3m)-2.46%
Valuation
Industry RankSector Rank
PE 20.85
Fwd PE 11.76
P/S 1.21
P/FCF 66.78
P/OCF 10.79
P/B 1.21
P/tB 2.91
EV/EBITDA 7.23
EPS(TTM)3.73
EY4.8%
EPS(NY)6.61
Fwd EY8.5%
FCF(TTM)1.16
FCFY1.5%
OCF(TTM)7.21
OCFY9.27%
SpS64.16
BVpS64.4
TBVpS26.71
PEG (NY)3.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.71%
ROE -1.3%
ROCE 5.83%
ROIC 4.38%
ROICexc 5%
ROICexgc 8.66%
OM 9.25%
PM (TTM) N/A
GM 31.11%
FCFM 1.81%
ROA(3y)2.81%
ROA(5y)0.13%
ROE(3y)7.26%
ROE(5y)-1.97%
ROIC(3y)8.47%
ROIC(5y)7.63%
ROICexc(3y)9.08%
ROICexc(5y)8.08%
ROICexgc(3y)19%
ROICexgc(5y)18.92%
ROCE(3y)11.29%
ROCE(5y)10.17%
ROICexcg growth 3Y-19.3%
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.3%
ROICexc growth 5YN/A
OM growth 3Y-4.48%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5YN/A
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 25.36
Debt/EBITDA 2.11
Cap/Depr 84.98%
Cap/Sales 9.42%
Interest Coverage 250
Cash Conversion 55.24%
Profit Quality N/A
Current Ratio 2.27
Quick Ratio 1.56
Altman-Z 2.32
F-Score4
WACC6.87%
ROIC/WACC0.64
Cap/Depr(3y)98.43%
Cap/Depr(5y)76.05%
Cap/Sales(3y)9.47%
Cap/Sales(5y)8.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-102.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67.55%
EPS Next Y6.78%
EPS Next 2Y12%
EPS Next 3Y12.22%
EPS Next 5Y7.94%
Revenue 1Y (TTM)-3.1%
Revenue growth 3Y4.31%
Revenue growth 5YN/A
Sales Q2Q%-7.14%
Revenue Next Year-1.27%
Revenue Next 2Y1.41%
Revenue Next 3Y2.41%
Revenue Next 5Y3.51%
EBIT growth 1Y-33.42%
EBIT growth 3Y-0.36%
EBIT growth 5YN/A
EBIT Next Year51.65%
EBIT Next 3Y21.42%
EBIT Next 5Y14.78%
FCF growth 1Y-85.81%
FCF growth 3Y-7.48%
FCF growth 5YN/A
OCF growth 1Y-52.53%
OCF growth 3Y7.55%
OCF growth 5YN/A